New Capital Management’s Novartis NVS Stock Holding History

New Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-84	Closed	-$6K	–	137
2018 Q3	$6K	Hold	84	–	–	0.01%	129
2018 Q2	$6K	Hold	84	–	–	0.01%	127
2018 Q1	$6K	Sell	84 -111	-57%	-$8.45K	0.02%	135
2017 Q4	$15K	Hold	195	–	–	0.02%	119
2017 Q3	$15K	Hold	195	–	–	0.03%	116
2017 Q2	$13K	Hold	195	–	–	0.02%	122
2017 Q1	$13K	Hold	195	–	–	0.02%	121
2016 Q4	$13K	Buy	+195	New	+$12.7K	0.02%	117

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

New Capital Management's NVS Position: Q4 2018 in Review

New Capital Management sold out of Novartis (NVS) in Q4 2018, closing a stake of 84 shares — an estimated $6K sold.

New Capital Management first reported a position in NVS in Q4 2016 and held it in 8 quarters. The position peaked at $15K in Q4 2017. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

New Capital Management reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
New Capital Management sold 84 Novartis shares in Q4 2018, an estimated $6K.
New Capital Management first reported a position in Novartis in Q4 2016 and held it in 8 quarters.
New Capital Management's Novartis position peaked at $15K in Q4 2017.
1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on New Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.